US approves Bavencio for bladder cancer
In a clinical trial, Bavencio maintenance treatment extended median overall survival by 50% over standard of care
Read More
Tag: EMD Serono
US speedy review for Merck, Pfizer’s avelumab
US regulators have agreed to undertake a priority review EMD Serono’s avelumab as a potential treatment for metastatic Merkel cell carcinoma (MCC), a rare and aggressive disease in which cancer cells form in the top layer of the skin, close to nerve endings.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
